We will email you to start the conversation.
Albert Labs CEO Dr. Michael Raymont tells Proactive it has been issued a Health Canada license enabling psilocybin possession, production, and delivery and also covers other psychoactive controlled substance.
© 2022 Albert Labs. All Rights Reserved
We are a pharmaceutical company leveraging our drug development and clinical research expertise to accelerate the development of highly effective mental health medicines.
If you would like support or more information around making an investment, please contact firstname.lastname@example.org